VHL and neoplasm: In contrast, with the exception of VHL, the frequency of mutations in individual candidate TSGs in RCC is <15% , however, we and others have identified at least 14 candidate TSGs demonstrating tumour-specific promoter methylation in >20% of RCC ([8,9], and references within).